Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Senthil Damodaran, Fengmin Zhao, Dustin A. Deming, Edith P. Mitchell, John Joseph Wright, Laurence A Doyle, Robert James Gray, Shuli Li, Lisa McShane, Larry V Rubinstein, David R Patton, Mickey Williams, Stanley R. Hamilton, Jennifer Marie Suga, Barbara A. Conley, Carlos L. Arteaga, Lyndsay Harris, Peter J. O'Dwyer, Alice P. Chen, Keith Flaherty | ||||||||||||
Title | Phase II study of copanlisib in patients with tumors with PIK3CA mutations (PTEN loss allowed): NCI MATCH EAY131-Z1F. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/185087/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 3506) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|